Clinical Trial Update: LIBERATE Trial in COVID-19 [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial (LIBERATE) investigating COVID-19 has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus
• Respiratory Distress Syndrome
• Sars-cov Infection

Snippet

Sponsor: King's College London | Conditions: Coronavirus, Respiratory Distress Syndrome | Phase 4 | Status: WITHDRAWN